Preclinical and First-In-Human Evaluation of Ribupatide (HRS9531), a Dual GLP-1/GIP Receptor Agonist.
- DOI
- 10.1111/dom.71218
- Published
- 2026 Sep 20
- Container
- Diabetes, obesity & metabolism
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dom.71218,
title = {Preclinical and First-In-Human Evaluation of Ribupatide (HRS9531), a Dual GLP-1/GIP Receptor Agonist.},
author = {He K and Wei Y and Zhao H and Zhang L and Wu F and Liu R and Zhang Y and Wang Y and Chen H and Zeng M and Zhi L and Zhou T and Sheng Z and Wen Q},
year = {2026},
journal = {Diabetes, obesity \& metabolism},
doi = {10.1111/dom.71218},
url = {https://doi.org/10.1111/dom.71218}
}RIS
TY - JOUR TI - Preclinical and First-In-Human Evaluation of Ribupatide (HRS9531), a Dual GLP-1/GIP Receptor Agonist. AU - He K AU - Wei Y AU - Zhao H AU - Zhang L AU - Wu F AU - Liu R AU - Zhang Y AU - Wang Y AU - Chen H AU - Zeng M AU - Zhi L AU - Zhou T AU - Sheng Z AU - Wen Q PY - 2026 JO - Diabetes, obesity & metabolism DO - 10.1111/dom.71218 UR - https://doi.org/10.1111/dom.71218 ER -
APA
K, H., Y, W., H, Z., L, Z., F, W., R, L., Y, Z., Y, W., H, C., M, Z., L, Z., T, Z., Z, S., & Q, W. (2026). Preclinical and First-In-Human Evaluation of Ribupatide (HRS9531), a Dual GLP-1/GIP Receptor Agonist.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.71218
Source records
- pubmed · retrieved 2026-09-24T21:40:00.615Z